[Early Structural Valve Deterioration of Bioprosthetic Mitral Valve in a Dialysis Patient]. 2022

Sho Takemoto, and Akimitsu Yamaguchi, and Hiroshi Kumano, and Moriichi Sugama, and Toru Uezu, and Norio Mori
Department of Cardiovascular Surgery, Northern Okinawa Medical Center, Nago, Japan.

Choice of prosthetic valve during valve replacement in dialysis patients is still controversial. There is a known risk of early structural valve deterioration of bioprosthesis in dialysis patients, whereas mechanical prosthesis is associated with a higher risk of bleeding and thrombotic events. A 68-year-old dialysis-dependent woman, who had undergone bioprosthetic mitral valve replacement at the age of 66, was admitted to our hospital because of general malaise and hypotension during dialysis. Echocardiography revealed severe mitral stenosis and regurgitation due to restricted motion and dense calcification in prosthetic valve leaflets, which indicated early structural valve deterioration. Redo mitral valve replacement using a mechanical valve was performed, and the patient gradually recovered. However, she eventually died of intracranial hemorrhage three months after the surgery.

UI MeSH Term Description Entries
D008943 Mitral Valve The valve between the left atrium and left ventricle of the heart. Bicuspid Valve,Bicuspid Valves,Mitral Valves,Valve, Bicuspid,Valve, Mitral,Valves, Bicuspid,Valves, Mitral
D008946 Mitral Valve Stenosis Narrowing of the passage through the MITRAL VALVE due to FIBROSIS, and CALCINOSIS in the leaflets and chordal areas. This elevates the left atrial pressure which, in turn, raises pulmonary venous and capillary pressure leading to bouts of DYSPNEA and TACHYCARDIA during physical exertion. RHEUMATIC FEVER is its primary cause. Mitral Stenosis,Mitral Stenoses,Mitral Valve Stenoses,Stenoses, Mitral,Stenoses, Mitral Valve,Stenosis, Mitral,Stenosis, Mitral Valve,Valve Stenoses, Mitral,Valve Stenosis, Mitral
D005260 Female Females
D006350 Heart Valve Prosthesis A device that substitutes for a heart valve. It may be composed of biological material (BIOPROSTHESIS) and/or synthetic material. Prosthesis, Heart Valve,Cardiac Valve Prosthesis,Cardiac Valve Prostheses,Heart Valve Prostheses,Prostheses, Cardiac Valve,Prostheses, Heart Valve,Prosthesis, Cardiac Valve,Valve Prostheses, Cardiac,Valve Prostheses, Heart,Valve Prosthesis, Cardiac,Valve Prosthesis, Heart
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001705 Bioprosthesis Prosthesis, usually heart valve, composed of biological material and whose durability depends upon the stability of the material after pretreatment, rather than regeneration by host cell ingrowth. Durability is achieved 1, mechanically by the interposition of a cloth, usually polytetrafluoroethylene, between the host and the graft, and 2, chemically by stabilization of the tissue by intermolecular linking, usually with glutaraldehyde, after removal of antigenic components, or the use of reconstituted and restructured biopolymers. Glutaraldehyde-Stabilized Grafts,Heterograft Bioprosthesis,Porcine Xenograft Bioprosthesis,Xenograft Bioprosthesis,Bioprostheses,Bioprostheses, Heterograft,Bioprostheses, Porcine Xenograft,Bioprostheses, Xenograft,Bioprosthesis, Heterograft,Bioprosthesis, Porcine Xenograft,Bioprosthesis, Xenograft,Glutaraldehyde Stabilized Grafts,Glutaraldehyde-Stabilized Graft,Graft, Glutaraldehyde-Stabilized,Grafts, Glutaraldehyde-Stabilized,Heterograft Bioprostheses,Porcine Xenograft Bioprostheses,Xenograft Bioprostheses,Xenograft Bioprostheses, Porcine,Xenograft Bioprosthesis, Porcine

Related Publications

Sho Takemoto, and Akimitsu Yamaguchi, and Hiroshi Kumano, and Moriichi Sugama, and Toru Uezu, and Norio Mori
December 2022, Journal of cardiac surgery,
Sho Takemoto, and Akimitsu Yamaguchi, and Hiroshi Kumano, and Moriichi Sugama, and Toru Uezu, and Norio Mori
May 2022, The Journal of thoracic and cardiovascular surgery,
Sho Takemoto, and Akimitsu Yamaguchi, and Hiroshi Kumano, and Moriichi Sugama, and Toru Uezu, and Norio Mori
April 2020, Cardiology research,
Sho Takemoto, and Akimitsu Yamaguchi, and Hiroshi Kumano, and Moriichi Sugama, and Toru Uezu, and Norio Mori
May 2015, The Journal of heart valve disease,
Sho Takemoto, and Akimitsu Yamaguchi, and Hiroshi Kumano, and Moriichi Sugama, and Toru Uezu, and Norio Mori
October 2019, The Thoracic and cardiovascular surgeon,
Sho Takemoto, and Akimitsu Yamaguchi, and Hiroshi Kumano, and Moriichi Sugama, and Toru Uezu, and Norio Mori
January 2012, Interactive cardiovascular and thoracic surgery,
Sho Takemoto, and Akimitsu Yamaguchi, and Hiroshi Kumano, and Moriichi Sugama, and Toru Uezu, and Norio Mori
January 2012, Kardiologia polska,
Sho Takemoto, and Akimitsu Yamaguchi, and Hiroshi Kumano, and Moriichi Sugama, and Toru Uezu, and Norio Mori
October 2008, The Annals of thoracic surgery,
Sho Takemoto, and Akimitsu Yamaguchi, and Hiroshi Kumano, and Moriichi Sugama, and Toru Uezu, and Norio Mori
January 2017, Methodist DeBakey cardiovascular journal,
Sho Takemoto, and Akimitsu Yamaguchi, and Hiroshi Kumano, and Moriichi Sugama, and Toru Uezu, and Norio Mori
January 2009, The Annals of thoracic surgery,
Copied contents to your clipboard!